SRINAGAR: The people of Kashmir who were already worried about the sale of spurious drugs, have a new worry to add to their list of health care woes. As per our reports, many known pharmaceutical companies are making quite a fortune in Kashmir by ... Kashmir Observer, 23 hours ago
Pharma prices regulator NPPA has revised the ceiling price of 54 formulations based on bulk drugs used for treatment of diseases, including cancer, diabetes rheumatoid arthritis, bacterial infections and hypertension. It has also fixed retail price of 11 ...The Financial Chronicle, 1 month ago
on your WebpageAdd Widget >Get your members hooked!